Early onset breast cancer in a registry-based sample of African-American women: BRCA mutation prevalence, and other personal and system-level clinical characteristics

Breast Journal

Volumn 19, Issue 2, 2013, Pages 189-192

  Pal, Tuya ^a   Bonner, Devon ^a   Kim, Jongphil ^a   Monteiro, Alvaro N A ^a   Kessler, Lisa ^b   Royer, Robert ^c   Narod, Steven A ^c   Vadaparampil, Susan T ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b DNA Direct by Medco   (United States)

^c WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

BRCA; Breast Cancer Health Disparities; Hereditary Breast Cancer

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AFRICAN AMERICAN; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER PATIENT; CANCER REGISTRY; CANCER SURGERY; CLINICAL ARTICLE; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HUMAN; INCOME; MASTECTOMY; PATIENT REFERRAL; PREVALENCE;

ADULT; AFRICAN AMERICANS; AGE OF ONSET; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MASTECTOMY; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; REGISTRIES;

EID: 84874718584     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/tbj.12083     Document Type: Article

References (23)

1. American Cancer Society I. Cancer Facts & Figures 2011. Internet] http://www.cancer.org/docroots/STT/stt-0.asp. Accessed 2011, 2011.
2. Lakhani SR, Reis-Filho JS, Fulford L, et al,. Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res 2005; 11: 5175-80.
3. Young SR, Pilarski RT, Donenberg T, et al,. The prevalence of BRCA1 mutations among young women with triple-negative breast cancer. BMC Cancer. 2009; 9: 86.
4. Antoniou A, Pharoah PD, Narod S, et al,. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003; 72: 1117-30.
5. Chen S, Parmigiani G,. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 2007; 25: 1329-33.
6. Litton JK, Ready K, Chen H, et al,. Earlier age of onset of BRCA mutation-related cancers in subsequent generations. Cancer 2012; 118: 321-5.
7. Graeser MK, Engel C, Rhiem K, et al,. Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 2009; 27: 5887-92.
8. Malone KE, Begg CB, Haile RW, et al,. Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. J Clin Oncol 2010; 28: 2404-10.
9. Newman LA,. Breast cancer in African-American women. Oncologist. 2005; 10: 1-14.
10. Pal T, Rocchio E, Garcia A, Rivers D, Vadaparampil S,. Recruitment of black women for a study of inherited breast cancer using a cancer registry-based approach. Genet Test Mol Biomarkers. 2011; 1-5: 69-77.
11. Genetic/Familial High-risk Assessment: Breast and Ovarian. NCCN Practice Guidelies [V.3.2011:http://www.nccn.org/professionals/physician-gls/recently- updated.asp. Accessed October 17, 2011.
12. Nanda R, Schumm LP, Cummings S, et al,. Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. JAMA 2005; 294: 1925-33.
13. Haffty BG, Choi DH, Goyal S, et al,. Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups. Ann Oncol 2009; 20: 1653-9.
14. Hall MJ, Reid JE, Burbidge LA, et al,. BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer 2009; 115: 2222-33.
15. Malone KE, Daling JR, Doody DR, et al,. Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res 2006; 66: 8297-308.
16. Wideroff L, Vadaparampil ST, Greene MH, Taplin S, Olson L, Freedman AN,. Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J Med Genet 2005; 42: 749-55.
17. Wideroff L, Vadaparampil ST, Breen N, Croyle RT, Freedman AN,. Awareness of genetic testing for increased cancer risk in the year 2000 National Health Interview Survey. Community Genet. 2003; 6: 147-56.
18. Vadaparampil ST, Quinn GP, Gjyshi A, Pal T,. Development of a brochure for increasing awareness of inherited breast cancer in black women. Genet Test Mol Biomarkers. 2011; 15: 59-67.
19. Arrington AK, Jarosek SL, Virnig BA, Habermann EB, Tuttle TM,. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol 2009; 16: 2697-704.
20. Murphy RX Jr, Adkinson JM, Namey T, Eid S, Bleznak A,. Surgical and financial implications of genetic counseling and requests for concurrent prophylactic mastectomy. Ann Plast Surg 2010; 64: 684-7.
21. Pal T, Stowe C, Cole A, Lee JH, Zhao X, Vadaparampil S,. Evaluation of phone-based genetic counselling in African American women using culturally tailored visual aids. Clin Genet 2010; 78: 124-31.
22. Vadaparampil S, Pal T,. Updating and refining a study brochure for a cancer registry-based study of BRCA mutations among young African American breast cancer patients: lessons learned. J Community Genet. 2010; 1: 63-71.
23. Kuperstein G, Jack E, Narod SA,. A fluorescent multiplex-DGGE screening test for mutations in the BRCA1 gene. Genet Test. Spring 2006; 10: 1-7.